Health Care

Commentary

‘Speak Out Act’ Hardly Pro-women

A new proposal in Congress aims to allow victims of sexual misconduct to go public with their stories. That goal is admirable. But — as written — the legislation, the Speak Out Act, which was introduced in both the House and Senate in recent weeks will force victims to go public, even if they don’t want to. That’s hardly pro-women. ...
Featured

Watch: Wayne Winegarden Discusses Impact of “Inflation Reduction” Bill on Innovation

Watch PRI’s Dr. Wayne Winegarden, director of the Center for Medical Economics and Innovation, discuss how the drug price control provisions in the so-called Inflation Reduction Act will impact innovation in an interview on NTD Business.
Commentary

Hospitals must be more transparent about health care costs

Some Illinois hospitals are keeping their prices secret from their patients. Only three out of a sample of 11 major medical facilities in the state are fully compliant with a federal rule requiring hospitals to publish the costs of common services, according to data from the nonprofit group PatientsRightsAdvocate.org. That includes hospitals ...
Blog

The Administrative State: Who is Really in Charge?

One somewhat overlooked but recent Supreme Court case contains potentially powerful implications for the private sector’s operational culture, especially in health care and education West Virginia v. EPA centered around the question of whether the Environmental Protection Agency has the authority to regulate how electricity is generated. Motivated to reduce ...
Featured

NEW BRIEF: Establishing An Efficient Health Insurance Market

DOWNLOAD THE BRIEF   Cultivating an efficient health insurance market requires reforms that empower patients over payers, which can be achieved by: Making health expenditures and health insurance expenditures tax deductible; Broadening the availability and usability of tax-free saving accounts to help patients cover the deductibles and out of pocket ...
Commentary

Drug price controls would limit new medicines

The Democrats’ budget reconciliation bill is winding its way through the Senate. Last week, Republican and Democratic senators met with the chamber’s parliamentarian to discuss whether the bill’s proposal for Medicare to negotiate the price of prescription drugs with manufacturers has a direct impact on government spending or tax revenue, as reconciliation ...
Commentary

Dems’ Reconciliation Bill Would Push US Economy Over Cliff

Inflation is at its highest level in four decades, according to federal data out last week. Senate Democrats say they have a solution — their newly revamped budget reconciliation bill, which would levy price controls on prescription drugs and provide billions in subsidies for health insurance sold through Obamacare’s exchanges. How this proposal ...
Commentary

Stop funneling more money toward failing Affordable Care Act

Democrats in Congress are scrambling to extend the enhanced Obamacare subsidies signed into law by President Biden last year as part of the American Rescue Plan Act. It’s no mystery why. If lawmakers allow these premium tax credits to expire — as they’re set to at the end of this year — ...
Blog

Drug Price Controls Are Not the Solution to Another Bad Inflation Report

The July 13th report on consumer price inflation (CPI-U) confirmed what we all already knew – prices have become unaffordable. Consumer price inflation rose 9.1 percent over the last year, which is the fastest inflation rate in 40+ years. The impetus for this current bout of inflation is not mysterious. ...
Commentary

It’s Time To Cure The FDA’s Regulatory Sclerosis

Late last month, the Food and Drug Administration advised COVID-19 vaccine manufacturers to develop booster shots aimed at the omicron variant of the virus. Regulators hope the shots will be ready by the fall. That will probably be too late to stop BA.5, the highly transmissible subvariant that has quickly become the dominant strain in ...
Commentary

‘Speak Out Act’ Hardly Pro-women

A new proposal in Congress aims to allow victims of sexual misconduct to go public with their stories. That goal is admirable. But — as written — the legislation, the Speak Out Act, which was introduced in both the House and Senate in recent weeks will force victims to go public, even if they don’t want to. That’s hardly pro-women. ...
Featured

Watch: Wayne Winegarden Discusses Impact of “Inflation Reduction” Bill on Innovation

Watch PRI’s Dr. Wayne Winegarden, director of the Center for Medical Economics and Innovation, discuss how the drug price control provisions in the so-called Inflation Reduction Act will impact innovation in an interview on NTD Business.
Commentary

Hospitals must be more transparent about health care costs

Some Illinois hospitals are keeping their prices secret from their patients. Only three out of a sample of 11 major medical facilities in the state are fully compliant with a federal rule requiring hospitals to publish the costs of common services, according to data from the nonprofit group PatientsRightsAdvocate.org. That includes hospitals ...
Blog

The Administrative State: Who is Really in Charge?

One somewhat overlooked but recent Supreme Court case contains potentially powerful implications for the private sector’s operational culture, especially in health care and education West Virginia v. EPA centered around the question of whether the Environmental Protection Agency has the authority to regulate how electricity is generated. Motivated to reduce ...
Featured

NEW BRIEF: Establishing An Efficient Health Insurance Market

DOWNLOAD THE BRIEF   Cultivating an efficient health insurance market requires reforms that empower patients over payers, which can be achieved by: Making health expenditures and health insurance expenditures tax deductible; Broadening the availability and usability of tax-free saving accounts to help patients cover the deductibles and out of pocket ...
Commentary

Drug price controls would limit new medicines

The Democrats’ budget reconciliation bill is winding its way through the Senate. Last week, Republican and Democratic senators met with the chamber’s parliamentarian to discuss whether the bill’s proposal for Medicare to negotiate the price of prescription drugs with manufacturers has a direct impact on government spending or tax revenue, as reconciliation ...
Commentary

Dems’ Reconciliation Bill Would Push US Economy Over Cliff

Inflation is at its highest level in four decades, according to federal data out last week. Senate Democrats say they have a solution — their newly revamped budget reconciliation bill, which would levy price controls on prescription drugs and provide billions in subsidies for health insurance sold through Obamacare’s exchanges. How this proposal ...
Commentary

Stop funneling more money toward failing Affordable Care Act

Democrats in Congress are scrambling to extend the enhanced Obamacare subsidies signed into law by President Biden last year as part of the American Rescue Plan Act. It’s no mystery why. If lawmakers allow these premium tax credits to expire — as they’re set to at the end of this year — ...
Blog

Drug Price Controls Are Not the Solution to Another Bad Inflation Report

The July 13th report on consumer price inflation (CPI-U) confirmed what we all already knew – prices have become unaffordable. Consumer price inflation rose 9.1 percent over the last year, which is the fastest inflation rate in 40+ years. The impetus for this current bout of inflation is not mysterious. ...
Commentary

It’s Time To Cure The FDA’s Regulatory Sclerosis

Late last month, the Food and Drug Administration advised COVID-19 vaccine manufacturers to develop booster shots aimed at the omicron variant of the virus. Regulators hope the shots will be ready by the fall. That will probably be too late to stop BA.5, the highly transmissible subvariant that has quickly become the dominant strain in ...
Scroll to Top